Apollomics announces updated strategic focus and leadership team changes

Focus on vebreltinib study enrollment for non-small cell lung cancer (nsclc) patients with met amplification mutations targets greatest unmet medical need focus on vebreltinib study enrollment for non-small cell lung cancer (nsclc) patients with met amplification mutations targets greatest unmet medical need
APLM Ratings Summary
APLM Quant Ranking